Cargando…
A specific plasminogen activator inhibitor‐1 antagonist derived from inactivated urokinase
Fibrinolysis is a process responsible for the dissolution of formed thrombi to re‐establish blood flow after thrombus formation. Plasminogen activator inhibitor‐1 (PAI‐1) inhibits urokinase‐type and tissue‐type plasminogen activator (uPA and tPA) and is the major negative regulator of fibrinolysis....
Autores principales: | Gong, Lihu, Proulle, Valerie, Fang, Chao, Hong, Zebin, Lin, Zhonghui, Liu, Min, Xue, Guangpu, Yuan, Cai, Lin, Lin, Furie, Barbara, Flaumenhaft, Robert, Andreasen, Peter, Furie, Bruce, Huang, Mingdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876229/ https://www.ncbi.nlm.nih.gov/pubmed/27197780 http://dx.doi.org/10.1111/jcmm.12875 |
Ejemplares similares
-
Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016) -
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
por: Kromann-Hansen, Tobias, et al.
Publicado: (2017) -
Targeted Gene Disruption Demonstrates That P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Required for P-Selectin–Mediated but Not E-Selectin–Mediated Neutrophil Rolling and Migration
por: Yang, Jing, et al.
Publicado: (1999) -
Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts
por: Chao, Shih-Chun, et al.
Publicado: (2011) -
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998)